SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

VolitionRx Signs LOI With Missionpharma for NETosis Technology Development

VolitionRx signed a letter of intent with Missionpharma to explore developing and launching Volition's lateral flow technology worldwide.

VNRX

Related stories